Using ANOVA, the percentage of patients with DM positive for anti-IA2 was 58.1%, which is significantly different from that of patients found positive for other autoantibodies (p<0.0001), and 9.7% of patients with DM were positive for anti-ZnT8 compared with controls (3.3%). Here, PTPRN is linked to diabetes mellitus.